baber/WOPTO huggingface dataset:
Patent CA-2511583-A1 (CA)
Title: Method for producing honeycomb catalyst, method for producing denitration catalyst of denitration device, and method for producing exhaust gas denitration device
Inventor: SHIRAKURA SHIGEO
IPC: B01J23/02
Filed: 2003-12-25
Abstract: An efficiently usable honeycomb catalyst , a denitration catalyst of a denitration device, and an exhaust gas denitration device capable of reducin g the running cost of an exhaust gas denitration system by the denitration catalyst to approx. half. The honeycomb catalyst comprises gas flow passages for feeding treated gas from the inlet side to the outlet side thereof, performs treatment on the side walls of the gas flow passages, and has such a length that the flow of the treated gas fed in the gas flow passages is generally streamlined near the outlet side thereof.
Patent CA-2511749-A1 (CA)
Inventor: LIN ZHEM MAN
IPC: A61K31/02
Filed: 2003-06-12
Abstract: SARS infection has wreaks havoc in China, Hong Kong and Taiwan and its effec ts sending repercussion throughout the entire international society. The death rate has been high and the Chinese and western medical social were quite helpless about hits. For more than hundreds of years, lung infectious diseas es have always been classified under medical science as internal organs disease . However, today, this paper will point out that this opinion has been misunderstood. There is a need to associate such infection disease with air as an interface. Therefore, SARS infection is a kind surface ulcerous infection . Since there have been changes from the above-mentioned medical science opinion, we have found the best medical scheme. It will no longer be a dream for SARS infected patients to be discharge from the hospital in a matter of hours. The SARS infected will no longer be life threatening again. Hence, mankind can proudly declare their triumph over SARS. "Surface Treatment infected of SARS infected lungs" is under the brand new medical concept of t he outcome. The "01 Therapy" is the core of the "Surface Treatment". The sterilizing liquid that is infected into the lung lobes is the surface treatment liquid for 01 therapy of the lungs. The formal name for this liqui d is Per Fluoro Chemical (PFC) and the sterilizing is ozone.
Patent CA-2511751-A1 (CA)
Inventor: TURNER ROBERT J
IPC: C12P13/04
Filed: 2003-10-15
Abstract: The present invention relates to specific E. coli mutants which can be used for the synthesis of D-amino acids, and to such a process. The mutants are distinguished by deficiencies in particular enzymes which break down D-amino acids.
Patent CA-2512596-A1 (CA)
Inventor: CAMPBELL MICHAEL T
IPC: B60R13/08
Filed: 2004-01-06
Abstract: An acoustical barrier (10) comprises a layer of molded firm-flexible foam (38) that is generally configured to match the acoustical requirements in an environment and mounted against a sound-transmitting substrate and can have one or more areas of patterned recesses (48) along a substrate-facing side or varying thickness tailored to the intensity of sound transmitted through the sound-transmitting substrate with or without a thin, impervious barrier layer overlying the foam layer.
Patent CA-2515148-A1 (CA)
Inventor: RYE PHILIP DESMOND
IPC: G01N33/68
Filed: 2004-02-06
Abstract: The present invention provides a method for assaying for a protein having at least two isoforms having different glycosylation patterns, said method comprising: contacting a sample containing said protein with a proteolytic enzyme, and detecting the content or relative content of at least one peptide fragment produced by proteolysis of said protein.
Patent CA-2516452-A1 (CA)
Inventor: TOFOVIC STEVAN P
IPC: A61K31/56
Filed: 2004-02-20
Abstract: Methods are provided for the treatment of pulmonary hypertension and other conditions associated therewith. In particular, the methods include treatment of pulmonary hypertension with estradiol metabolite or estradiol metabolite associated with biodegradable microparticles or nanoparticles alone or in combination with another therapeutic agent. Preferred estradiol metabolites include 2-methoxyestradiol, 4-methoxyestradiol, 2-hydroxyestradiol, and 4-hydroxyestradiol, and/or to synthetic derivatives and analogues thereof or prodrugs thereof. The compositions may also be in the form of a controlled release formulation.
Patent CA-2516462-A1 (CA)
Title: Craniofacial fracture reduction assembly
Inventor: HAMEL ROSS
IPC: A61B17/66
Filed: 2004-02-20
Abstract: A craniofacial fracture reduction assembly (10) comprising a reduction platform (50) and a threaded fragment manipulator (100). A receiving hole (70) in the reduction platform (50) is configured to accept the fragment manipulator (100). The fragment manipulator (100) may comprise a bone engaging portion (106) and a center threaded adjustment portion (110). A reduction nut (125) controls a fragment reduction vector. An adjustable support assembly (150) may be used to position the reduction platform (50) above the fracture region.
Patent CA-2517475-A1 (CA)
Title: Balancing damper
Inventor: VATSKY JOEL
IPC: F23D1/00
Filed: 2004-03-05
Abstract: An apparatus (26) for use in a furnace system to facilitate efficient and complete combustion of coal streams in a carrier gas. The apparatus (26) , capable of being positioned horizontally or vertically in the coal pipes (24, 24-1, 24-2) between the grinding mills (20) and the furnace burner (32), contains a plurality of adjustable blades (40, 41) that are movable between an open and closed position. The position of the adjustable blades and the differing geometric shapes of the apparatus housing (42) manipulate the amount and direction of coal streams in a carrier gas. This design reduces the amount of turbulent eddies in the pipe system, which helps to achieve a more homogenous flow of coal in a carrier gas and the efficient and complete combustion of coal in a carrier gas within the furnace burner (32).
Patent CA-2519495-A1 (CA)
Inventor: LOCKWOOD GREGORY T
IPC: B21K5/02
Filed: 2005-09-13
Abstract: An insert for a drill bit that includes diamond particles disposed in a matrix material, wherein the diamond particles have a contiguity of 15% or less is disclosed. A method of forming a diamond-impregnated cutting structure, that includes loading a plurality of substantially uniformly coated diamond particles into a mold cavity, pre-compacting the substantially uniformly coated diamond particles using a cold-press cycle, and heating the compacted, substantially uniformly coated diamond particles with a matrix material to form the diamond impregnated cutting structure is also disclosed.
Patent CA-2519661-A1 (CA)
Title: Mixer with optional faucet
Inventor: DANIELS THOMAS E JR
IPC: A47J43/06
Filed: 2005-09-15
Abstract: A food mixer device and method includes a container configured to receive food. A pair of interchangeable container bases are each separately and removably couplable to the container. At least one mixing assembly is rotatably disposed in the container. A faucet is operatively coupled to one of the interchangeable container bases.
Patent CA-2520357-A1 (CA)
Title: Flame retardant thermoset resins and methods of making the same
Inventor: DESCHATELETS PASCAL
IPC: C08K5/49
Filed: 2004-04-22
Abstract: Articles and processes are provided whereby flame-retardant SAP particles are incorporated into synthetic resins, especially curable thermosettable resins.  The SAP particles are most preferably hydrated with an aqueous flame-retardant solution. In this regard, the flame-retardant solution may consist essentially of water alone or a water solution containing one or more water soluble inorganic flame retardants. When SAP particles are hydrated with an aqueous inorganic flame retardant solution, the SAP particles may thereafter be dried to remove substantially the water component. In such a manner, the inorganic flame retardant will remain as a dried residue physically entrained within the SAP particles. As such, the SAP particles serve as a physical matrix in which the inorganic flame retardant is homogenously dispersed. The SAP particles may then be blended with a synthetic resin as is or alternatively may be ground into more finely divided particles which contain the dried residue of the aqueous inorganic flame retardant solution and then blended with a suitable synthetic resin.
Patent CA-2522324-A1 (CA)
Title: Diffuser of air-freshening products for vehicles
Inventor: CASERTA ANDREA
IPC: B60H3/00
Filed: 2003-09-18
Abstract: The body of the diffuser, which has a front semi-body and a back semi-body (2), defines two cylindrical and coaxial necks -a bottom (5) and a top neck (12)-, which are open towards the outside in such a way that the bottom neck (5) tightly engages with the neck (6) of the container (7) that supplies the air freshener product while the rotatable shutter (14) engages in the top neck (12) that is provided with an inner, perimetric rib (13), said shutter extending toward the outside of the body and forming a manual actuation knob (16) while defining two diametrically opposed cylindrical flaps (17) toward the inside of the body, which surround the wick (8) associated with the container (7). Said flaps can face to a greater or lesser degree the screened areas (10) of the front and back semi-bodies (2) so that less or more freshener air will pass through the body thereby affecting the wick (8) depending on the angular position of the shutter (14).
Patent CA-2522692-A1 (CA)
Title: Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
Inventor: PICATAGGIO STEPHEN K
IPC: C12Q1/68
Filed: 2004-05-07
Abstract: The present invention relates to fatty acid desaturases and elongases able to catalyze the conversion of linoleic acid (LA) to .gamma.-linolenic acid (GLA);  .alpha.-linoleic acid (ALA) to stearidonic acid (STA); GLA to dihomo-.gamma.-linoleic acid (DGLA); STA to eicosatetraenoic acid (ETA); DGLA to ETA;  eicosapentaenoic acid (EPA) to docosapentaenoic acid (DPA); and arachidonic acid (ARA) to EPA. Nucleic acid sequences encoding codon-optimized desaturases and elongases, nucleic acid sequences which hybridize thereto, DNA constructs comprising the codon-optimized desaturase or elongases, and recombinant host microorganisms expressing increased levels of desaturase or elongase are described.
Patent CA-2523426-A1 (CA)
Title: Aza spiro alkane derivatives as inhibitors of metalloproteases
Inventor: METCALF BRIAN
IPC: C07D401/02
Filed: 2004-04-23
Abstract: The present invention provides a compound of Formula I or Formula II:  enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein.  The compounds of Formula (I) and (II) are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions.
Patent CA-2529066-A1 (CA)
Title: Compact pifa antenna for automated manufacturing
Inventor: TRACY JAMES L
IPC: H01Q1/24
Filed: 2004-06-09
Abstract: An RF Parallel Inverted "F" Antenna (PIFA) antenna (101) that is suitable for incorporation into wireless devices constructed with automated manufacturing techniques. The PIFA antenna (101) includes a first arm (102) and a parallel second arm (104) connected by a conductive bridge (106). An RF feed (108) is attached to one end of the first arm (102) and is used to physically and electrically mount the compact PIFA antenna (101). An opposite end of the compact PIFA antenna (101) includes a support structure (150) that provides stability and support of the compact PIFA antenna (101) during construction of a circuit board on which it is mounted. The end support (150) is designed to minimize the use of insulating material to minimize dielectric effects upon the radiation pattern of the conductive elements of the compact PIFA antenna (101) all while maximizing the mechanical stability of the component during secondary manufacturing operations.
Patent CA-2529085-A1 (CA)
Inventor: GRAHAM RONALD A
IPC: B22F1/062
Filed: 2004-06-30
Abstract: A method of producing metal fibers including melting a mixture of at least a fiber metal and a matrix metal, cooling the mixture to form a bulk matrix comprising at Ieast a fiber phase and a matrix phase and removing at Ieast a substantial portion of the matrix phase from the fiber phase. Additionally, the method may inciude deforming the bulk matrix. In certain embodiments, the fiber metal may be at Ieast one of niobium, a niobium alloy, tantalurn and a tantalum alloy and the matrix metal may be at Ieast one of copper and a copper alloy. The substantial portion of the matrix phase may be removed, in certain erbodiments, by dissolving of the matrix phase in a suitabie minerai acid, such as, but not Iimited to, nitric acid, sulfuric acid, hydrochioric acid and phosphoric acid.
Patent CA-2529778-A1 (CA)
Inventor: ROSENHAHN CARSTEN
IPC: C01G49/02
Filed: 2005-12-13
Abstract: The present invention relates to reduction- and oxidation-stable iron oxide black pigments having high colour strength, the preparation thereof and the use thereof.
Patent CA-2529871-A1 (CA)
Inventor: BUNGE RAINER
IPC: C03C14/00
Filed: 2004-06-21
Abstract: A granulate that consists of broken pieces of a sintered body (21, 21') that is sintered from crushed blow-molded glass has a number of inclusions of at least one active substance (17, 27) on the broken surfaces of granulate (21, 21'). This active substance (17, 27) is embedded as a grain in sintered body (21, 21'). Upon contact with toxins, in particular with toxins that are suspended or dissolved in water, this active substance can interact with these toxins. Such a granulate can be produced very readily relative to active substance, compressive strength, specific weight, grain size, etc., and can be used correspondingly in a versatile manner. Despite arsenic- or antimony-containing starting substances, it can be used, for example, in the form of foam glass broken pieces as a construction material in environmentally-sensitive areas. It can be used, e.g., in the form of expanded or unexpanded sintered bodies in water purification. Depending on the intended use, metals, in particular metallic iron, active carbon or else water-soluble substances, can be used as active substances.
Patent CA-2529971-A1 (CA)
Inventor: DUTTA ARUNAVA
IPC: H01J61/40
Filed: 2005-12-13
Abstract: A method of increasing low temperature lumen maintenance of an electrodeless lamp whose glass body has an interior surface with red emitting Y2O3:Eu (YOE) phosphors and green emitting (Ce,Tb)MgAl11O19 (CAT) phosphors thereon, includes coating aluminum oxide directly on the CAT phosphors and/or the YOE phosphors (preferably at least the CAT phosphors). The interior surface of the glass body may also have blue emitting BaMgAl11O17:Eu (BAM) phosphors thereon. The low temperature lumen maintenance is a ratio of (a) lamp lumens at a first number of lamp operating hours to (b) lamp lumens at a reference number of lamp operating hours, when the lamp is operated with a bulb wall temperature of 35°C or lower.
Patent CA-2533451-A1 (CA)
Inventor: SAYRE RICK
IPC: G06T13/00
Filed: 2004-03-23
Abstract: A method for a computer system includes posing a 3D model (500) in a first configuration, determining a first 2D (510) view of the 3D model in the first configuration, posing the 3D model in a second configuration (550), determining a second 2D (570) view of the 3D model in the second configuration, associating a first 2D image with the first 2D view of the model, associating a second 2D (570) image with the second 2D view of the model, associating a first set of surface parameters with a surface of the 3D  model that is visible in the first 2D view in response to the first 2D image and the first configuration for the 3D model, and associating a second set of surface parameters with a surface of the 3D model that is visible in the second 2D view in response to the second 2D image and the second configuration for the 3D model.
Patent CA-2534083-A1 (CA)
Title: Fuel for jet, gas turbine, rocket, and diesel engines
Inventor: CONNOR DANIEL STEDMAN
IPC: C10L1/04
Filed: 2004-07-22
Abstract: A fuel or fuel blendstocks for jet, gas turbine, rocket, and diesel engines, particularly jet and rocket engines utilizing components of conventional petroleum not currently utilized for jet, gas turbine, rocket, and diesel fuels, such as benzene, butanes, butanes, and methyl tert butyl ether (MTBE) alklyated with aromatic moieties to make monoaromatics used in jet and diesel fuels. Additionally, a fuel having such monoaromatics has multiple desired properties such as higher flash point, low pour point, increased density, better lubricity, aerobic degradability, reduction in toxicity, and additionally can deliver benefits in blendstocks.
Patent CA-2536007-A1 (CA)
Title: Additive for oil compositions
Inventor: TACK ROBERT DRYDEN
IPC: C10L1/192
Filed: 2006-02-10
Abstract: An additive composition comprises at least one polyoxyalkylene compound and at least one ethylene polymer, wherein the at least one ethylene polymer, in addition to units derived from ethylene, comprises units of the formula (I): (see figure I) and optionally, units of the formula (II): (see figure II) wherein each R1 group independently represents hydrogen or methyl; wherein each R2 group independently represents an alkyl group having 5 or more carbon atoms; wherein each R3 group independently represents hydrogen or methyl; wherein each R4 group independently represents an alkyl group having between 1 and 4 carbon atoms; wherein the proportion of units of formula (I) in the ethylene polymer is between 16 and 30mol%; and wherein the total proportion of units of formula (I) and formula (II) in the ethylene polymer is between 19 and 30mol%. The composition is particularly suitable for improving the low temperature properties of fuels having sharp distillation tails and low final boiling points.
Patent CA-2538073-A1 (CA)
Title: Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane
Inventor: WANG MIAN-YING
IPC: A61B/
Filed: 2004-09-10
Abstract: The present invention advances prior art techniques, formulations, and methods for treating mammary breast cancer during its initial phases, as well as for preventing mammary breast cancer, by providing a safe, nutraceutical formulation comprising Morinda citrifolia, methylsulfonylmethane (MSM), and other ingredients.
Patent CA-2539797-A1 (CA)
Inventor: KENLEY RICKY LEE
IPC: D04H1/60
Filed: 2004-09-07
Abstract: A method and apparatus for making an absorbent composite from continuous tow is disclosed. The method and apparatus includes the steps of or means for spreading a crimped tow; de-registering the crimped tow; shaping the de-registered tow to a substantially rectangular cross-section; and distributing a particulate onto the shaped tow. The method and apparatus also include the step of or means for shielding the tow, while de-registering, from contaminants.
Patent CA-2542504-A1 (CA)
Inventor: PELLED DORI
IPC: A23L33/00
Filed: 2004-10-21
Abstract: Disclosed is a lipid preparation comprising a glycerophospholipid or salt, conjugate and derivatives thereof, particularly phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidyl-inositol (PI), phosphatidylglycerol (PG) and phosphatidic acid (PA), and poly-unsaturated fatty acid (PUFA) acyl groups, particularly long-chain poly-unsaturated fatty acid (LC-PUFA) acyl groups such as omega-3 and/or omega-6 acyl groups, wherein said PUFA is covalently bound to said glycerophospholipid. The disclosed preparations possess an improved bioactivity, and are useful in the treatment of various cognitive and mental conditions and disorders and for maintenance of normal functions of brain-related systems and processes, for example ADHD.
Patent CA-2543131-A1 (CA)
Inventor: SWEETING MICHAEL
IPC: G06Q40/00
Filed: 2004-10-19
Abstract: Published without an Abstract
Patent CA-2543586-A1 (CA)
Inventor: KOLARI MARKO
IPC: C12Q1/00
Filed: 2004-11-05
Abstract: The invention is directed to a method for detecting the presence of biofilm-forming microorganisms in a paper or board making process for determining the need of an anti-biofilm agent in the process. The method comprises the steps:  (a) subjecting a sampler device in the process line for a period of time to enable said microorganisms to form a biofilm in situ in said process on the surface of the sampler, (b) optionally treating said formed biofilm in a solution of a test anti-biofilm agent for a period of time, then (c) contacting said biofilm with a liquid growth medium in a recession of a culturing device for a period of time, and (d) removing the growth solution from the recession of said device and detecting qualitatively and/or quantitatively the presence or absence of a biofilm adhered on the walls of the recession. An assembly kit is also provided.
Patent CA-2547774-A1 (CA)
Title: Method for making pharmaceutical multiparticulates
Inventor: APPEL LEAH ELIZABETH
IPC: A61K9/14
Filed: 2004-11-24
Abstract: A process for forming drug multiparticulates having improved drug crystallinity is disclosed, comprising modifying a conventional melt-congeal process by adding a volatile cospecies either to the molten mixture or to the process atmosphere, or to both.
Patent CA-2548282-A1 (CA)
Inventor: WICKRAMASINGHE DINELI M
IPC: A61K38/08
Filed: 2004-12-10
Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by regulating c-met dimerization and/or binding of ligand to c-met using a c-met antagonist that disrupts c-met multimerization.
Patent CA-2549765-A1 (CA)
Inventor: SPRAVE RAINER
IPC: B61G1/32
Filed: 2006-06-09
Abstract: This invention relates to a joint arrangement (1) for a coupling, more particularly for an articulated joint coupling or a central buffer coupling, for the purpose of joining in an articulated manner two adjacent wagon boxes (100, 101) of a multi-member vehicle, particularly a rail vehicle. The joint arrangement has a first pivoting part (2), a second pivoting part (3) and a joint bolt (4). The first and the second pivoting parts (2, 3) interact by means of the vertically running joint bolt (4), about a common swiveling axis (21), as defined by the joint bolt (4). In order to prevent freezing of the joint arrangement at low ambient temperatures and thus limiting operation thereof, the joint bolt is equipped with a heating element (5) for heating the joint arrangement.
Patent CA-2550258-A1 (CA)
Title: Oligomeric compounds for the modulation of bcl-2
Inventor: THRUE CHARLOTTE ALBAECK
IPC: C07H21/02
Filed: 2004-12-23
Abstract: The present invention provides improved oligomeric compound, in particular oligonucleotide compounds, and methods for modulating the expression of the Bcl-2 gene in humans. In particular, this invention relates to oligomeric compounds of 10-30 nucleobases in length which comprise a target binding domain that is specifically hybridizable to a region ranging from base position N~1459 (5~) to N~1476 (3~) of the human Bcl-2 mRNA, said target binding domain having the formula: 5~-[DNA/RNA)0-1-(LNA/LNA*)2-7-(DNA/RNA/LNA*)4-14-(LNA/LNA*)2-7-(DNA/RNA)0-1]-3~ and said target binding domain comprising at least two LNA nucleotides or LNA analogue nucleotides linked by a phosphorothioate group (-O-P(O,S)-O). In particular the oligo is predominantly or fully thiolated. The invention also provides the use of such oligomers or conjugates or chimera for the treatment of various diseases associated with the expression of the Bcl-2 gene, such as cancer.